Business
ARIUS responds to recent market activity
TORONTO, May 16 /CNW/ - ARIUS Research Inc., (TSX: ARI), a biotechnology company discovering and ...
About this update from Affinity Metals Corp
[{"type":"text","content":"\n\n\n\nTORONTO, May 16 /CNW/ - ARIUS Research Inc., (TSX: ARI), a biotechnology\ncompany discovering and developing the next wave of antibody therapeutics,\ntoday responded to an inquiry by Market Regulation Services of the Toronto\nStock Exchange, regarding market activity of the Company's shares.\n\n\nAs previously presented at its annual general meeting of shareholders, as\npart of its ongoing strategic development and in the normal course of its\nbusiness, ARIUS continues to evaluate its strategic options with global\npharmaceutical and biotechnology companies. Through this process, some third\nparties have shown interest in the Company and its technologies. At this\nstage, the Company has not entered into any agreement with any such third\nparty. There are no assurances that this activity will result in any specific\ntransaction and no specific timetable for the completion of any transaction is\ncurrently known. In addition, ARIUS has been presenting at various scientific\nand investor meetings, and will be presenting several abstracts at ASCO 2008.\n\n\nAbout ARIUS\n\n\nARIUS is a biotechnology company discovering and developing the next wave\nof antibody therapeutics. Established in 1999, ARIUS has built a proprietary\ntechnology platform, FunctionFIRST(TM), that rapidly identifies and selects\nantibodies based on their functional ability to affect disease. This antibody\ngeneration engine has enabled ARIUS to assemble a portfolio of more than 500\nantibody candidates. In addition to the antibodies it is developing in-house,\nARIUS has ongoing partnerships with key biotechnology and drug development\ncompanies. ARIUS is listed on the TSX under the symbol "ARI". For further\ninformation, visit www.ariusmabs.com\n\n\nForward-Looking Statements\n\n\nCertain statements in this news release constitute "forward-looking\nstatements" within the meaning of the Private Securities Litigation Reform Act\nof 1995, which involve known and unknown risks, uncertainties and other\nfactors that may cause our actual results to be materially different from any\nfuture results, performance or achievements expressed or implied by such\nstatements. Forward-looking statements in this release include, but are not\nlimited to, ARIUS successfully advancing its new product programs as well as\nlicensing opportunities. These stat...